Radiotherapy with hyperthermia for patients with high-risk prostate cancer; a multicenter prospective observational study

Not Applicable

Recruiting

• Conditions: Prostate cancer

• Registration Number: JPRN-UMIN000050538
• Lead Sponsor: Aichi Medical University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-03-08
• Last Update Posted: 17 October 2023
• Study Completion: 2026-06-30

Recruitment & Eligibility

• Status: Recruiting
• Sex: Male
• Target Recruitment: 200

Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients with multiple cancers (simultaneous multiple cancers or iatrogenic multiple cancers with a disease-free interval of 5 years or less).However, intraepithelial cancer, lesions equivalent to intramucosal cancer, and skin cancer are not included in overlapping cancers. 2) Patients who have a history of irradiation (re-irradiation) at the same site as the current irradiation. 3) Patients who will be treated with three-dimensional source body irradiation 4) Patients who will not receive concomitant endocrine therapy 5) Patients who are scheduled to receive concomitant small source radiation therapy 6) Patients who are judged by the principal investigator to be inappropriate for enrollment in this study.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
5-year biochemical recurrence-free survival rate

Secondary Outcome Measures

Name	Time	Method
3/5/8-year overall/cause-specific /clinical recurrence-free survival rate, Adverse event rate, Transitions in the IPSS and QOL scores